B12-MIC

Energy, metabolic methylation

Status

Available at launch

Mechanism

A compounded blend of methylcobalamin (B12) and MIC (methionine, inositol, choline). B12 supports methylation, neurological function, and red blood cell synthesis. The MIC lipotropic factors assist hepatic fat metabolism and choline-dependent phospholipid synthesis, commonly used as an adjunct to weight-management protocols.

Indications

→B12 deficiency (common with metformin and GLP-1 use)

→Energy and fatigue support

→Lipid metabolism and hepatic fat processing

→Methylation cycle support

Regulatory status

Compounded methylcobalamin and MIC are eligible for 503A pharmacy preparation. Not FDA-approved as a combined formulation.

References

01Pawlak R, et al. The prevalence of cobalamin deficiency among vegetarians assessed by serum vitamin B12. Eur J Clin Nutr. 2014.

02FDA 503A Bulk Drug Substances List — eligible.

This fact sheet is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Compounded medications are not FDA-approved. Prescribing decisions are made by a licensed clinician based on individual medical necessity. Not all patients qualify.